Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-020382

Chief Medical Officer sold 866 shares at $8.06 ($6,980)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rottinghaus Scott T. Chief Medical Officer 2024-12-06 Sale 10b5-1 −866 $8.06 $6,980 17,918 D: show line 1 in the form
Open-market sales · 866 sh · avg $8.06 · $6,980
Loading xslF345X05/form4.xml…